Denmark's economy boosted by anti-obesity treatments
Should Ozempic come with a warning about a risk of suicidal thoughts?
Weight-loss drug maker Novo Nordisk becomes Europe's most valuable
Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says - The
Ozempic-maker Novo Nordisk briefly becomes Europe's most valuable firm
Novo Nordisk hikes full-year forecast on GLP-1 drug sales
Wegovy Maker Novo Nordisk's Profit Surges on Weight-Loss-Drug
New ground for Novo: Denmark's largest company just keeps getting
Ozempic, Wegovy maker Novo Nordisk is now the largest company in
Ozempic, Wegovy maker Novo Nordisk is now the largest company in
Novo's Wegovy supply rebound on track for later this year as
Ozempic, Wegovy demand drives up illegal sales of weight-loss drugs
Novo Nordisk Becomes Europe's Most Valuable Company